Targeting the secretory program of 3q-amplified lung cancers

Luis Pardo1, Jim C Norman1,2

  • 1Cancer Research UK Scotland Institute, Glasgow, United Kingdom.

Insights

Researchers found that targeting secretory pathways in 3q-amplified cancers using manganese (Mn2+) can block tumor progression. This strategy degrades Golgi integral membrane protein 4 (GOLIM4), impacting cancer cell survival and recruitment of stromal cells.

Area of Science:

  • Oncology
  • Cell Biology
  • Cancer Research

Background:

  • Targeting cancer cell proliferation is a key research area.
  • Secretory programs in cancer cells influence survival, migration, and tumor stroma interactions.
  • 3q-amplified cancers represent a specific group of malignancies.

Purpose of the Study:

  • To investigate the functional cooperativity between Golgi-resident proteins GOLIM4 and ATP2C1 in 3q-amplified cancers.
  • To explore the therapeutic potential of targeting the secretory program in these cancers.

Main Methods:

  • Described functional cooperativity between Golgi integral membrane protein 4 (GOLIM4) and ATPase secretory pathway Ca2+ transporting 1 (ATP2C1).
  • Utilized manganese (Mn2+) to target 3q-amplified tumors.
  • Assessed the impact of Mn2+ treatment on GOLIM4 degradation and secretory blockade in mice models.

Main Results:

  • Functional cooperativity between GOLIM4 and ATP2C1 was identified in coordinating secretory programs.
  • Manganese (Mn2+) treatment promoted GOLIM4 degradation in targeted tumors.
  • A secretory blockade was imposed, impairing tumor progression and stromal cell recruitment in mice.

Conclusions:

  • The secretory program is a viable therapeutic target in 3q-amplified malignancies.
  • Targeting GOLIM4 and ATP2C1 offers a promising strategy to treat tumor progression.
  • This approach could lead to novel therapeutic strategies for specific cancer types.